BOVE, PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 194
EU - Europa 123
AS - Asia 40
AF - Africa 8
SA - Sud America 1
Totale 366
Nazione #
US - Stati Uniti d'America 193
GB - Regno Unito 30
IT - Italia 29
DE - Germania 27
CN - Cina 16
SE - Svezia 11
SG - Singapore 11
IE - Irlanda 6
FR - Francia 5
IN - India 5
HK - Hong Kong 4
EE - Estonia 3
JO - Giordania 3
TG - Togo 3
ES - Italia 2
GR - Grecia 2
NG - Nigeria 2
RU - Federazione Russa 2
ZA - Sudafrica 2
BG - Bulgaria 1
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
ID - Indonesia 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
UA - Ucraina 1
Totale 366
Città #
Fairfield 36
Houston 30
Southend 29
Woodbridge 19
Ashburn 14
Wilmington 11
Cambridge 10
Bologna 9
Seattle 9
Singapore 9
Chandler 7
Dublin 6
Princeton 6
Hong Kong 4
Amman 3
Changsha 3
Lomé 3
Redwood City 3
Santa Clara 3
Westminster 3
Abeokuta 2
Boardman 2
Florence 2
Los Angeles 2
New York 2
Ozzano 2
Scuola 2
Torino 2
Triggiano 2
Turin 2
Abidjan 1
Ann Arbor 1
Berlin 1
Foggia 1
Groningen 1
Guangzhou 1
Jakarta 1
Kumar 1
Lausanne 1
Muizenberg 1
Nanchang 1
Nanjing 1
Nanning 1
Norwalk 1
Oslo 1
Palma Campania 1
Paris 1
Phoenix 1
Plauen 1
Redmond 1
Saint Petersburg 1
San Diego 1
Shanghai 1
Sofia 1
Taiyuan 1
Tianjin 1
Toronto 1
Warsaw 1
Totale 265
Nome #
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study. 180
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer. 108
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study. 91
Totale 379
Categoria #
all - tutte 909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202071 0 0 0 0 0 12 13 18 14 4 7 3
2020/202162 16 3 4 10 3 0 2 1 9 3 2 9
2021/202254 1 2 2 10 3 3 0 3 3 5 13 9
2022/202349 4 5 3 4 4 2 2 2 12 5 3 3
2023/202423 0 6 1 3 1 3 2 5 0 2 0 0
2024/202529 3 4 4 5 7 6 0 0 0 0 0 0
Totale 379